POTENTIAL RISK
FACTORS
Learn More
PULMONARY FIBROSIS
SYMPTOMS
Learn More
SIGNS OF PULMONARY
FIBROSIS
Learn More
PULMONARY FIBROSIS
TREATMENT
Learn More
ABOUT US
Our team comprise of highly dedicated multidisciplinary physicians (lung specialists, chest radiologists, pathologists, thoracic surgeons and rheumatologists), nurses and support staff who supply state-of-the-art, comprehensive and prompt evaluations and treatment recommendations. We are dedicated to providing continuous education and support to patients and their families on a daily basis. Simultaneously, our education sessions on pulmonary fibrosis and pulmonary hypertension are constantly present for physicians and other healthcare providers to access.
In 2008, Professor Esam H. Alhamad established The Interstitial (ILD) and Pulmonary Hypertension (PH) Center at King Saud University Medical City. The center is made of a multidisciplinary team for patients with pulmonary fibrosis and pulmonary hypertension. Our team comprise of highly dedicated multidisciplinary physicians (lung specialists, chest radiologists, pathologists, thoracic surgeons and rheumatologists), nurses and support staff who supply state-of-the-art, comprehensive and prompt evaluations and treatment recommendations.
PULMONARY FIBROSIS
The term “Pulmonary” refers to lung while “Fibrosis” means scar tissue; similar to scars present on the skin due to old injuries or surgeries.
Thus, pulmonary fibrosis refers to lung scarring and eventual tissue scarring that would consequently hinder oxygen from entering the bloodstream. Ultimately, low oxygen levels (and the rigid scar tissue itself) lead to shortness of breath particularly when walking or exercising.